Showing results (371-380 of 461) with videos related to
Sort By:
Pageof 47
British Journal of Haematology|March 6, 2010
Final analysis of the UKLG LY02 trial comparing 6-8 cycles of CHOP with 3 cycles of CHOP followed by a BEAM autograft in patients <65 years with poor prognosis histologically aggressive NHLDavid C Linch, Lynny Yung, Paul Smith, et al.Bone Marrow Transplantation|March 14, 2019
Author Correction: High-dose chemotherapy and autologous stem cell transplantation in enteropathy-associated and other aggressive T-cell lymphomas: a UK NCRI/Cancer Research UK Phase II StudyElizabeth H Phillips, Michelle M Lannon, Andre Lopes, et al.European Radiology|June 28, 2018
Whole-body MRI for staging and interim response monitoring in paediatric and adolescent Hodgkin's lymphoma: a comparison with multi-modality reference standard including 18F-FDG-PET-CTArash Latifoltojar, Shonit Punwani, Andre Lopes, et al.Leukemia|February 27, 2024
Long-term outcomes by bone marrow B-cell depletion from the R2W trial of bortezomib with cyclophosphamide and rituximab in Waldenstrőm macroglobulinaemiaRuth de Tute, Nicholas Counsell, Laura Clifton-Hadley, et al.The American Journal of Pathology|April 23, 2013
Anti-IL-17A treatment reduces clinical score and VCAM-1 expression detected by in vivo magnetic resonance imaging in chronic relapsing EAE ABH miceSilvy Mardiguian, Sébastien Serres, Emma Ladds, et al.The EMBO Journal|January 4, 2026
Pervasive phenotypic effects of FBXO42 are promoted by regulation of PP4 phosphataseHongbin Yang, Paul Smith, Yingying Ma, et al.Journal of the National Cancer Institute|February 8, 2007
Myocardial infarction mortality risk after treatment for Hodgkin disease: a collaborative British cohort studyAnthony J Swerdlow, Craig D Higgins, Paul Smith, et al.Nucleic Acids Research|April 28, 2026
K63-linked ubiquitylation of S2P-RNAPII regulates transcription in a DNAPK inter-dependent manner in response to double-strand breaksVasiliki Pantazi, Paul Smith, Zoltan G Pahi, et al.Journal of Immunology (Baltimore, Md. : 1950)|January 23, 2008
Fast progression of recombinant human myelin/oligodendrocyte glycoprotein (MOG)-induced experimental autoimmune encephalomyelitis in marmosets is associated with the activation of MOG34-56-specific cytotoxic T cellsYolanda S Kap, Paul Smith, S Anwar Jagessar, et al.Plos One|May 28, 2016
Multi-Center Randomized Phase II Study Comparing Cediranib plus Gefitinib with Cediranib plus Placebo in Subjects with Recurrent/Progressive GlioblastomaNicholas Brown, Catherine McBain, Stephen Nash, et al.Pageof 47